3,4-Dihydroxymethcathinone (HHMC), or 3,4-dihydroxy-N-methylcathinone, is a monoamine releasing agent of the amphetamine and cathinone families. It is an active metabolite of methylone (3,4-methylenedioxymethcathinone; MDMC). The drug is a norepinephrine–dopamine releasing agent (NDRA), with EC50Tooltip half-maximal effective concentration values of 110 nM for norepinephrine, 90 nM for dopamine, and 14,100 nM for serotonin in rat brain synaptosomes. HHMC was first described in the scientific literature by 2017.
See also 4-Hydroxy-3-methoxymethcathinone (HMMC; 4-HO-3-MeO-MC) α-Methyldopamine (3,4-dihydroxyamphetamine; HHA; 3,4-DHA) α-Methylepinine (3,4-dihydroxymethamphetamine; HHMA, 3,4-DHMA) 4-Hydroxy-3-methoxyamphetamine (HMA) 4-Hydroxy-3-methoxymethamphetamine (HMMA)
References
External links 3,4HO-MC - Isomer Design